Clinical Trials

10 enrolled 7 charts

Breast Neoplasms

NCT06411678 2025-06-17

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

50 enrolled

Phase EARLY_PHASE1 Enrolling by invitation

Breast Neoplasms

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

10 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

20 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT06145399 2025-05-18

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT03685175 2025-03-30

HPCardiotox

79 enrolled

Breast Neoplasms

NCT06637306 2025-03-26

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

15 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06756295 2025-03-12

FAST-CR

154 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT04674722 2024-12-09

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

43 enrolled

Breast Neoplasms

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

10 enrolled

Breast Neoplasms

NCT03911453 2024-10-03

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

20 enrolled

Breast Neoplasms

NCT04481230 2024-10-01

CARSPECT

6 enrolled

Breast Neoplasms, Osteoarthritis, Knee

NCT02913430 2024-09-23

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

7 enrolled 13 charts

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02415387 2024-07-24

IMPACT

172 enrolled 14 charts

Breast Neoplasms, Depression

NCT05549024 2024-07-05

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

90 enrolled

BreastCNSGenitourinary

Brain Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT03542695 2024-06-24

64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

1 enrolled

Breast Neoplasms, Calcinosis

NCT04925817 2024-06-07

3D Ultrasound Microvessel Imaging for Breast Masses

50 enrolled

Breast Neoplasms

NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

10 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

NCT06090630 2024-04-17

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

83 enrolled

Breast Neoplasms

NCT06361264 2024-04-11

Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

20 enrolled

Breast Neoplasms

NCT01916122 2024-04-05

Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status

54 enrolled

Phase EARLY_PHASE1 Terminated

Breast Neoplasms

NCT03361800 2024-03-25

Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC

5 enrolled

Phase EARLY_PHASE1 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04721886 2024-02-15

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

25 enrolled